This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burguera, B. Articles by Turner, R. T. Search for Related Content PubMed PubMed Citation Articles by Burguera, B. Articles by Turner, R. T.

Leptin Reduces Ovariectomy-Induced Bone Loss in Rats

Division of Endocrinology, University of Pittsburgh Medical Center (B.B.), Pittsburgh, Pennsylvania 15261; Divisions of Gastroenterology (L.C.H.) and Endocrinology, Zentrum fuer Innere Medizin, Philipps University, Marburg D-35033, Germany; Endocrine Research Unit (T.T., F.G., S.K., L.R.) and Department of Orthopedics (G.L.E., R.T.T.), Mayo Clinic, Rochester, Minnesota 55905

Address all correspondence and requests for reprints to: Barto Burguera, M.D., Ph.D., Division of Endocrinology, E-1140 BST, University of Pittsburgh Medical Center. Pittsburgh, Pennsylvania 15261. E-mail: burguerab{at}msx.dept-med.pitt.edu

Bone mineral density increases with fat body mass, and obesity has a protective effect against osteoporosis. However, the relationship between fat body mass and bone mineral density is only partially explained by a combination of hormonal and mechanical factors. Serum leptin levels are strongly and directly related to fat body mass. We report here the effects of leptin administration compared with estrogen therapy on ovariectomy-induced bone loss in rats. Leptin was effective at reducing trabecular bone loss, trabecular architectural changes, and periosteal bone formation. Interestingly, the combination of estrogen and leptin further decreased bone turnover compared with that in estrogen-treated ovariectomized rats. Leptin also significantly increased osteoprotegerin mRNA steady state levels and protein secretion and decreased RANK ligand mRNA levels in human marrow stromal cells in vitro. Our findings suggest that leptin could modulate bone remodeling in favor of a better bone balance in rats. This study is the first evidence that leptin therapy has a significant effect in preventing ovariectomy-induced bone loss, and this effect may at least in part be mediated by the osteoprotegerin/RANK ligand pathway.

This article has been cited by other articles:

				D. T. Villareal, K. Shah, M. R. Banks, D. R. Sinacore, and S. Klein Effect of Weight Loss and Exercise Therapy on Bone Metabolism and Mass in Obese Older Adults: A One-Year Randomized Controlled Trial J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2181 - 2187. [Abstract] [Full Text] [PDF]

				I. Barbaric, M. J. Perry, T. N. Dear, A. Rodrigues Da Costa, D. Salopek, A. Marusic, T. Hough, S. Wells, A. J. Hunter, M. Cheeseman, et al. An ENU-induced mutation in the Ankrd11 gene results in an osteopenia-like phenotype in the mouse mutant Yoda Physiol Genomics, February 19, 2008; 32(3): 311 - 321. [Abstract] [Full Text] [PDF]

				S. Tatsumi, M. Ito, Y. Asaba, K. Tsutsumi, and K. Ikeda Life-Long Caloric Restriction Reveals Biphasic and Dimorphic Effects on Bone Metabolism in Rodents Endocrinology, February 1, 2008; 149(2): 634 - 641. [Abstract] [Full Text] [PDF]

				A. Martin, V. David, L. Malaval, M.-H. Lafage-Proust, L. Vico, and T. Thomas Opposite Effects of Leptin on Bone Metabolism: A Dose-Dependent Balance Related to Energy Intake and Insulin-Like Growth Factor-I Pathway Endocrinology, July 1, 2007; 148(7): 3419 - 3425. [Abstract] [Full Text] [PDF]

				M. Misra, K. K. Miller, J. Cord, R. Prabhakaran, D. B. Herzog, M. Goldstein, D. K. Katzman, and A. Klibanski Relationships between Serum Adipokines, Insulin Levels, and Bone Density in Girls with Anorexia Nervosa J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2046 - 2052. [Abstract] [Full Text] [PDF]

				M. W. Hamrick Leptin and Bone: A Consensus Emerging? IBMS BoneKEy, March 1, 2007; 4(3): 99 - 107. [Abstract] [Full Text] [PDF]

				D. T. Villareal, L. Fontana, E. P. Weiss, S. B. Racette, K. Steger-May, K. B. Schechtman, S. Klein, and J. O. Holloszy Bone Mineral Density Response to Caloric Restriction-Induced Weight Loss or Exercise-Induced Weight Loss: A Randomized Controlled Trial Arch Intern Med, December 11, 2006; 166(22): 2502 - 2510. [Abstract] [Full Text] [PDF]

				P. Simic, J. B. Culej, I. Orlic, L. Grgurevic, N. Draca, R. Spaventi, and S. Vukicevic Systemically Administered Bone Morphogenetic Protein-6 Restores Bone in Aged Ovariectomized Rats by Increasing Bone Formation and Suppressing Bone Resorption J. Biol. Chem., September 1, 2006; 281(35): 25509 - 25521. [Abstract] [Full Text] [PDF]

				S. B. Choi, J. S. Jang, and S. Park Estrogen and Exercise May Enhance {beta}-Cell Function and Mass via Insulin Receptor Substrate 2 Induction in Ovariectomized Diabetic Rats Endocrinology, November 1, 2005; 146(11): 4786 - 4794. [Abstract] [Full Text] [PDF]

				K Rousseau, Z Atcha, J Denton, F R A Cagampang, A R Ennos, A J Freemont, and A S I Loudon Skeletal bone morphology is resistant to the high amplitude seasonal leptin cycle in the Siberian hamster J. Endocrinol., September 1, 2005; 186(3): 475 - 479. [Abstract] [Full Text] [PDF]

				A. Martin, R. de Vittoris, V. David, R. Moraes, M. Begeot, M.-H. Lafage-Proust, C. Alexandre, L. Vico, and T. Thomas Leptin Modulates both Resorption and Formation while Preventing Disuse-Induced Bone Loss in Tail-Suspended Female Rats Endocrinology, August 1, 2005; 146(8): 3652 - 3659. [Abstract] [Full Text] [PDF]

				M. W. Hamrick Leptin Regulation of Bone Mass by the Sympathetic Nervous System and CART IBMS BoneKEy, June 1, 2005; 2(6): 23 - 27. [Full Text] [PDF]

				R. Abou Samra, N. H. Baba, N. Torbay, L. Dib, and G. E.-H. Fuleihan High Plasma Leptin Is Not Associated with Higher Bone Mineral Density in Insulin-Resistant Premenopausal Obese Women J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2588 - 2594. [Abstract] [Full Text] [PDF]

				A. Matsunuma, T. Kawane, T. Maeda, S. Hamada, and N. Horiuchi Leptin Corrects Increased Gene Expression of Renal 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase and -24-Hydroxylase in Leptin-Deficient, ob/ob Mice Endocrinology, March 1, 2004; 145(3): 1367 - 1375. [Abstract] [Full Text] [PDF]

				A. Ghazali, F. Grados, R. Oprisiu, D. Bunea, P. Moriniere, N. El Esper, I. El Esper, M. Brazier, J. C. Souberbielle, A. Fournier, et al. Bone mineral density directly correlates with elevated serum leptin in haemodialysis patients Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1882 - 1890. [Abstract] [Full Text] [PDF]

				V. Simha, J. E. Zerwekh, K. Sakhaee, and A. Garg Effect of Subcutaneous Leptin Replacement Therapy on Bone Metabolism in Patients with Generalized Lipodystrophy J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 4942 - 4945. [Abstract] [Full Text] [PDF]

				S. Khosla Editorial: Leptin--Central or Peripheral to the Regulation of Bone Metabolism? Endocrinology, November 1, 2002; 143(11): 4161 - 4164. [Full Text] [PDF]

				M. Kveiborg, R. Chiusaroli, N. A. Sims, M. Wu, G. Sabatakos, W. C. Horne, and R. Baron The Increased Bone Mass in {Delta}FosB Transgenic Mice Is Independent of Circulating Leptin Levels Endocrinology, November 1, 2002; 143(11): 4304 - 4309. [Abstract] [Full Text] [PDF]

				J. Rubin, C. L. Ackert-Bicknell, L. Zhu, X. Fan, T. C. Murphy, M. S. Nanes, R. Marcus, L. Holloway, W. G. Beamer, and C. J. Rosen IGF-I Regulates Osteoprotegerin (OPG) and Receptor Activator of Nuclear Factor-{kappa}B Ligand in Vitro and OPG in Vivo J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4273 - 4279. [Abstract] [Full Text] [PDF]

				B. A. Kaufman, M. P. Warren, J. E. Dominguez, J. Wang, S. B. Heymsfield, and R. N. Pierson Bone Density and Amenorrhea in Ballet Dancers Are Related to a Decreased Resting Metabolic Rate and Lower Leptin Levels J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2777 - 2783. [Abstract] [Full Text] [PDF]

				H. Blain, A. Vuillemin, F. Guillemin, R. Durant, B. Hanesse, N. de Talance, B. Doucet, and C. Jeandel Serum Leptin Level Is a Predictor of Bone Mineral Density in Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1030 - 1035. [Abstract] [Full Text] [PDF]